Physician profile
Omar Krad
NPI 1669635132
$26,499.59
in general payments reported to CMS, 2019-2025
28 companies · $5,306 in 2025
The $5,306 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,262 · 2020: $1,851 · 2021: $1,841 · 2022: $1,308 · 2023: $6,433 · 2024: $5,500 · 2025: $5,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Food and Beverage: $5,362 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,675 · Travel and Lodging: $376 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Food and Beverage | $5,362.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,675.00 |
| Travel and Lodging | $375.74 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $8,927.97 | 2019-2025 | Rocklatan, Rhopressa, Clareon |
| Glaukos Corporation | $6,077.31 | 2019-2025 | Idosetr, Istent Infinite |
| Rxsight INC | $1,562.04 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Allergan, INC. | $1,445.03 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $1,374.74 | 2023-2025 | Stellaris Elite, Envista Aspire Iol, Teneo |
| Johnson & Johnson Surgical Vision, INC. | $1,372.75 | 2019-2025 | Tecnis Simplicity |
| Amgen INC. | $714.61 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $687.23 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $643.08 | 2019-2021 | |
| Abbvie INC. | $464.52 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $454.88 | 2019-2021 | |
| Oyster Point Pharma, INC. | $437.57 | 2023 | Tyrvaya |
| Sight Sciences, INC. | $352.27 | 2020-2024 | Tearcare System, Omni Surgical System |
| Horizon Therapeutics Plc | $315.09 | 2020-2023 | Tepezza |
| Beaver-Visitec International, INC. | $213.73 | 2019-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $208.85 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $144.69 | 2022 | |
| Astellas Pharma US INC | $134.29 | 2025 | Izervay |
| Ani Pharmaceuticals, INC. | $124.99 | 2025 | Purified Cortrophin Gel |
| Kala Pharmaceuticals, INC. | $124.18 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $119.87 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $115.32 | 2021-2023 | |
| Apellis Pharmaceuticals, INC. | $114.73 | 2025 | Syfovre |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $110.24 | 2025 | |
| Shire North American Group INC | $95.16 | 2019 | |
| Biotronik INC. | $69.45 | 2022 | |
| Dompe US, INC. | $53.65 | 2025 | Oxervate |
| Ocular Therapeutix, INC. | $41.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Krad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.